No Data
No Data
Fortress Biotech Reduces Total Debt and Enters Into New $35 Million Term Loan With Oaktree With Maturity in 2027
Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
Checkpoint Therapeutics Announces Alignment With FDA Enabling Upcoming Cosibelimab BLA Resubmission
Fortress Biotech Inc Series A P To Go Ex-Dividend On June 14th, 2024 With 0.19531 USD Dividend Per Share
10-Q: Quarterly report
Journey Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company Showcase
No Data